The first-in-human clinical study of SRP-1005, known as INSIGHTT, is expected to begin in the second quarter of 2026CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the ...

Shares US Infrastructure ETF offers equal-weighted exposure to 157 infrastructure stocks with 24% projected EPS growth and ...

Student loan refinance rates have dropped again slightly at the beginning of February. As of February 5, 2026, student loan ...

President Ferdinand R. Marcos Jr. is avoiding “executive overreach” in the release of the Statements of Assets, Liabilities and Net Worth (SALNs) of House lawmakers, particularly those under ...

Slightly more than 47,000 people have filed claims in a class action suit over the 2024 RIBridges data breach, according to a court filing Thursday from the court-appointed settlement administrator.

As New Zealand considers proposals to restrict teenagers’ access to social media, new research shows parents want solutions that put them in the driver’s seat — and they strongly support a practical ...

Intel’s Core Ultra lineup of desktop and laptop processors has been frustrating to review. None of them have been ...

The oncolytic virus therapy landscape has expanded steadily over the past decade, with over 100 companies worldwide pursuing clinical or preclinical programs. A few leaders, such as Candel ...

He is the first Spanish-language artist to win the ceremony’s top prize. Kendrick Lamar with SZA took record of the year, and Billie Eilish won song of the year. Lady Gaga, Olivia Dean and Lola Young ...

Slope is the only end-to-end, vendor-agnostic platform for managing biospecimens and clinical inventory across the entire clinical research ecosystem. Trusted by 2,200+ sites in 23+ countries, Slope ...

If the FDA follows through with the proposed guidelines, and they are not fatally twisted by pressure from the medical ...

Researchers report that vagus nerve stimulation helped many people with long-standing, treatment-resistant depression feel ...